ArticleCommunications biology2018

Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform.

Rachel L Graham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.